Life of a pharmacologist or the rich life of a poor metabolizer

Related Experiment Videos

¹Department of Pharmacology, University of Toronto, Ontario, Canada.

Pharmacology & Toxicology

|April 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine.

The pharmacogenomics journal·2006

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.

Journal of clinical psychopharmacology·2002

Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine.

European journal of clinical pharmacology·2001

CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.

Journal of clinical psychopharmacology·2001

What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

Drug safety·2001

Perspectives in pharmacogenetics.

Archives of pathology & laboratory medicine·2001

See all related articles